Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Medicx Launches PROximity HCP For Micro-Neighborhood® Targeting of Healthcare Practitioners


NEW YORK, May 22, 2018 /PRNewswire/ -- Medicx Media Solutions, a data-driven addressable marketing technology platform for the pharmaceutical and healthcare industries, today announced the launch of PROximity HCP. Leveraging Medicxs' coveted real world evidence-based healthcare data and Micro-Neighborhood® targeting provides pharmaceutical advertisers a more efficient way to reach their target healthcare practitioner audiences with a greater return on investment than traditional tactics.

Traditional online targeting of HCP's has been limited to healthcare professional endemic sites. In doing so, a brand limits its opportunity to reach practitioners when they are actually behaving like consumers and are equally or even more likely to be online, or in front of a TV.

"Improving communication in healthcare is an important piece to providing better health outcomes for patients and providers," said Michael Weintraub, CEO of Medicx. "By Leveraging our Micro-Neighborhood® marketing technology, we have the ability to help our customers develop a multichannel approach at a local, personalized level, which will improve consumer engagement. We're excited about the development and early success of PROximity HCP and have seen significant customer adoption already in driving incremental campaign revenue amongst our top 20 advertisers."

PROximity HCP is an extended reach to the vast Medicx database of over 4.1MM HCPs (Physicians, Nurse Practitioners, Physician Assistants Pharmacists, Hospitalists). PROximity HCP is available for both 1:1 (with affirmative express consent opt-in) targeting and is HIPAA certified for Micro-Neighborhood® targeting thus, it ensures brand safety advertisers engage in both 1:1 and hyper-targeted campaigns.

About Medicx

Medicx is the preeminent data-driven addressable marketing technology platform disrupting advertising for pharmaceutical and other healthcare industries. Through a patent-pending analytical and HIPAA-certified Micro-Neighborhood® targeting approach, Medicx creates highly-targeted marketing and media campaigns. Medicx tracks 35M+ Micro-Neighborhoods®, encompassing 240M+ adult patients and practitioners. The result is an unprecedented way to find and engage with the right audiences across multiple platforms and channels.

Medicx Tagline Logo (PRNewsfoto/Medicx Media Solutions)

 

SOURCE Medicx Media Solutions


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: